Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Archives of Neurology

• Publication date

  2012-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1001/ARCHNEUROL.2012.1070PMID 22801723PMCID PMC3683865
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 2013 Alzheimer's disease facts and figures

  2013cited by this paper
• Cerebrospinal fluid cortisol concentrations in healthy elderly are affected by both APOE and TOMM40 variants.

  2012cited by this paper
• Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance.

  2012cited by this paper
• Prediction of Alzheimer's disease using midregional proadrenomedullin and midregional proatrial natriuretic peptide: a retrospective analysis of 134 patients with mild cognitive impairment.

  2011cited by this paper
• Identification of a blood-based biomarker panel for classification of Alzheimer's disease.

  2011cited by this paper
• Diagnosis of Alzheimer's Disease Based on Disease-Specific Autoantibody Profiles in Human Sera

  2011cited by this paper
• The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis

  2011cited by this paper
• Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Haploinsufficiency of Human APOE Reduces Amyloid Deposition in a Mouse Model of Amyloid-β Amyloidosis

  2011cited by this paper
• Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides.

  2011cited by this paper
• Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's disease.

  2011cited by this paper
• Diagnosis of Parkinson's Disease Based on Disease-Specific Autoantibody Profiles in Human Sera

  2011cited by this paper
• The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• A Novel Blood Test for the Early Detection of Alzheimer's Disease

  2011cited by this paper
• 2011 Alzheimer's disease facts and figures

  2011cited by this paper
• A Gene Expression Pattern in Blood for the Early Detection of Alzheimer's Disease

  2011cited by this paper
• Plasma apolipoprotein E and Alzheimer disease risk

  2011cited by this paper
• Identification of candidate IgG biomarkers for Alzheimer's disease via combinatorial library screening.

  2011cited by this paper
• B-type natriuretic peptide as a predictor of declining cognitive function and dementia—a cohort study of an elderly general population with a 5-year follow-up

  2010cited by this paper
• Blood-based biomarkers of microvascular pathology in Alzheimer's disease.

  2010cited by this paper
• Novel CSF biomarkers for Alzheimer’s disease and mild cognitive impairment

  2010cited by this paper
• Revising the definition of Alzheimer's disease: a new lexicon.

  2010cited by this paper
• Glial cells as sources and targets of natriuretic peptides.

  2010cited by this paper
• A serum protein-based algorithm for the detection of Alzheimer disease.

  2010cited by this paper
• Age, neuropathology, and dementia.

  2009cited by this paper
• B-type natriuretic peptide plasma levels are elevated in subcortical vascular dementia

  2009cited by this paper
• Identifying Early Markers of Alzheimer's Disease using Quantitative Multiplex Proteomic Immunoassay Panels

  2009cited by this paper
• Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Aβ 1–42 ratios in CSF in patients with mild Alzheimer’s disease dementia

  2009cited by this paper
• AddNeuroMed—The European Collaboration for the Discovery of Novel Biomarkers for Alzheimer's Disease

  2009cited by this paper
• Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels

  2008cited by this paper
• Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

  2007cited by this paper
• Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.

  2007cited by this paper
• Proteome-based plasma biomarkers for Alzheimer's disease.

  2006cited by this paper
• Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia.

  2006cited by this paper
• Mining biomarkers in human sera using proteomic tools

  2004cited by this paper
• Regulation of human eotaxin-3/CCL26 expression: modulation by cytokines and glucocorticoids.

  2002cited by this paper
• Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide.

  1996cited by this paper
• A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

  1983cited by this paper

• Changes in the Public IgM Repertoire and Its Idiotypic Connectivity in Alzheimer’s Disease and Frontotemporal Dementia

  2025cites this paper
• Machine learning algorithms and traditional statistical models for detection of dementia: a population-based study.

  2025cites this paper
• Cross-tissue immune profiling of APOE ε4 reveals early dysregulation in Alzheimer’s disease

  2025influential citation
• IL-6 and Olfactory Dysfunction: Focus on Changes, Effects, and Mechanisms

  2025cites this paper
• Brain interleukins and Alzheimer’s disease

  2025cites this paper
• Impact of Manganese on Neuronal Function: An Exploratory MultiOmic Study on Ferroalloy Workers in Brescia, Italy

  2025cites this paper
• Impact of Manganese on Neuronal Function: An Exploratory Multi-Omics Study on Ferroalloy Workers in Brescia, Italy

  2025cites this paper
• Plasma Proteomic Signatures for Alzheimer's Disease: Comparable Accuracy to ATN Biomarkers and Cross‐Platform Validation

  2025cites this paper
• Advances in Blood Biomarkers and Diagnosis Approaches for Neurodegenerative Dementias and Related Diseases.

  2024cites this paper
• Detection and Classification of MRI Images using Multistage Classifier for Early Prediction of Alzheimer’s Disease

  2024cites this paper
• Role and Diagnostic Significance of Apolipoprotein D in Selected Neurodegenerative Disorders

  2024influential citation
• ADNI Biomarker Core: A review of progress since 2004 and future challenges

  2024cites this paper
• Biomarker Methodologies: A NIMH Perspective.

  2024cites this paper
• ONDSA: a testing framework based on Gaussian graphical models for differential and similarity analysis of multiple omics networks

  2024cites this paper
• The Bio‐Hermes Study: Biomarker database developed to investigate blood‐based and digital biomarkers in community‐based, diverse populations clinically screened for Alzheimer's disease

  2024cites this paper
• Multimodal brain-derived subtypes of Major depressive disorder differentiate patients for anergic symptoms, immune-inflammatory markers, history of childhood trauma and treatment-resistance.

  2024cites this paper
• Association of postoperative delirium with serum and cerebrospinal fluid proteomic profiles: a prospective cohort study in older hip fracture patients

  2024cites this paper
• Induced pluripotent stem cell models as a tool to investigate and test fluid biomarkers in Alzheimer's disease and frontotemporal dementia

  2024cites this paper
• APOE genotype and brain amyloid are associated with changes in the plasma proteome in elderly subjects without dementia

  2024cites this paper
• From Organotypic Mouse Brain Slices to Human Alzheimer’s Plasma Biomarkers: A Focus on Nerve Fiber Outgrowth

  2024cites this paper
• Accelerated cognitive aging in chronically infected HIV-1 positive individuals despite effective long-term antiretroviral therapy

  2024cites this paper
• A plasma protein signature associated with cognitive function in men without severe cognitive impairment

  2023influential citation
• Genome-wide analysis identifies novel loci influencing plasma apolipoprotein E concentration and Alzheimer’s disease risk

  2023cites this paper
• Peripheral inflammatory biomarkers are associated with cognitive function and dementia: Framingham Heart Study Offspring cohort

  2023cites this paper
• Altered granulocyte count and erythrocyte measures in middle-aged, healthy carriers of APOE and PICALM risk genes for Alzheimer's disease.

  2023cites this paper
• Neuroinflammation, Its Role in Alzheimer’s Disease and Therapeutic Strategies

  2023cites this paper
• Association of markers of inflammation on attention and neurobehavioral outcomes in survivors of childhood acute lymphoblastic leukemia

  2023cites this paper
• Biology of Tenascin C and its role in physiology and pathology.

  2023cites this paper
• Peripheral immune cell imbalance is associated with cortical beta-amyloid deposition and longitudinal cognitive decline

  2023cites this paper
• Review on Alzheimer Disease Detection Methods: Automatic Pipelines and Machine Learning Techniques

  2023cites this paper
• Independent APOE4 knock‐in mouse models display reduced brain APOE protein, altered neuroinflammation, and simplification of dendritic spines

  2022cites this paper
• ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies

  2022cites this paper
• Promising protein biomarkers in the early diagnosis of Alzheimer’s disease

  2022cites this paper
• Therapeutic approaches of nutraceuticals in the prevention of Alzheimer's disease.

  2022cites this paper
• inMTSCCA: An Integrated Multi-task Sparse Canonical Correlation Analysis for Multi-omic Brain Imaging Genetics

  2022cites this paper
• Prognosis of Alzheimer’s Disease Using Quantitative Mass Spectrometry of Human Blood Plasma Proteins and Machine Learning

  2022cites this paper
• [Clinical and immunological effects of choline alfoscerate in the treatment of amnestic type Mild Cognitive Impairment].

  2022cites this paper
• Causal effects of circulating cytokine concentrations on risk of Alzheimer’s disease and cognitive function

  2022cites this paper
• Role of Inflammatory Cytokines in the Conversion of Mild Cognitive Im- pairment to Dementia: A Prospective Study.

  2022cites this paper
• Identification of Plasma Proteomic Biomarkers in Patients with Mild Cognitive Impairment

  2022cites this paper
• Alzheimer's Disease: A Silent Pandemic - A Systematic Review on the Situation and Patent Landscape of the Diagnosis.

  2022cites this paper
• Apolipoprotein E Genotype e2: Neuroprotection and Its Limits

  2022cites this paper
• Persistent Depletion of Neuroprotective Factors Accompanies Neuroinflammatory, Neurodegenerative, and Vascular Remodeling Spectra in Serum Three Months after Non-Emergent Cardiac Surgery

  2022cites this paper
• Comparison of intact protein and digested peptide techniques for high throughput proteotyping of ApoE

  2022cites this paper
• Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer’s disease

  2022cites this paper
• Astrocytes as a Therapeutic Target in Alzheimer’s Disease–Comprehensive Review and Recent Developments

  2022cites this paper
• Impact of APOE genotype on prion-type propagation of tauopathy

  2022cites this paper
• Combination of Serum and Plasma Biomarkers Could Improve Prediction Performance for Alzheimer’s Disease

  2022cites this paper
• Risk of subsequent dementia or Alzheimer's disease among patients with age-related macular degeneration: A systematic review and meta-analysis.

  2022cites this paper
• Pre-symptomatic reduction of individuality in the AppNL-F knock-in model of Alzheimer’s disease

  2022cites this paper
• Identifying associations among genomic, proteomic and imaging biomarkers via adaptive sparse multi-view canonical correlation analysis

  2021cites this paper
• Serum NT‐proBNP levels are associated with cognitive functions in hemodialysis patients

  2021cites this paper
• Associations Between Tenascin-C and Testosterone Deficiency in Men with Major Depressive Disorder: A Cross-Sectional Retrospective Study

  2021cites this paper
• The Extracellular Matrix Glycoprotein Tenascin C and Adult Neurogenesis

  2021cites this paper
• A Machine-Learning-Based Assessment Method for Early-Stage Neurocognitive Impairment by an Immersive Virtual Supermarket

  2021cites this paper
• Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk

  2021cites this paper
• Levels of Angiotensin-Converting Enzyme and Apolipoproteins Are Associated with Alzheimer’s Disease and Cardiovascular Diseases

  2021cites this paper
• Large‐scale plasma proteomic profiling identifies a high‐performance biomarker panel for Alzheimer's disease screening and staging

  2021cites this paper
• Investigating Effects of Plasma Apolipoprotein E on Ischemic Heart Disease Using Mendelian Randomization Study

  2021cites this paper
• Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's disease

  2021cites this paper
• Alterations in cyclic nucleotide signaling are implicated in healthy aging and age-related pathologies of the brain.

  2021cites this paper
• The Role of Tenascin-C in Tissue Injury and Repair After Stroke

  2021cites this paper
• Age and sex specific effects of APOE genotypes on ischemic heart disease and its risk factors in the UK Biobank

  2021cites this paper
• A protective signal between the brain’s supporting cells in Alzheimer’s disease

  2021cites this paper
• A meta-analysis method for identifying potential blood based protein markers associated with Alzheimer’s disease

  2021influential citation
• Astrocytic interleukin-3 programs microglia and limits Alzheimer’s disease

  2021cites this paper
• Nutraceuticals-based therapeutic approach: recent advances to combat pathogenesis of Alzheimer’s disease

  2021cites this paper
• Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer’s and Parkinson’s Diseases

  2020cites this paper
• Causal effects of circulating cytokine concentrations on risk of Alzheimers disease: A bidirectional two-sample Mendelian randomization study

  2020cites this paper
• Plasma pro- and anti-inflammatory cytokines may relate to cocaine use, cognitive functioning, and depressive symptoms in cocaine use disorder

  2020cites this paper
• Pleiotropic Role of Tenascin-C in Central Nervous System Diseases: From Basic to Clinical Applications

  2020cites this paper
• Proteomic Profiling of Plasma and Brain Tissue from Alzheimer’s Disease Patients Reveals Candidate Network of Plasma Biomarkers

  2020cites this paper
• Plasma Protein Panels for Mild Cognitive Impairment Among Elderly Chinese Individuals with Different Educational Backgrounds

  2020cites this paper
• Phosphodiesterase Inhibitors for Alzheimer’s Disease: A Systematic Review of Clinical Trials and Epidemiology with a Mechanistic Rationale

  2020cites this paper
• Proteomics as a reliable approach for discovery of blood-based Alzheimer's disease biomarkers: a systematic review and meta-analysis.

  2020cites this paper
• CDH6 and HAGH protein levels in plasma associate with Alzheimer’s disease in APOE ε4 carriers

  2020cites this paper
• Alzheimer’s Disease Susceptibility Gene Apolipoprotein E (APOE) and Blood Biomarkers in UK Biobank (N = 395,769)

  2020cites this paper
• Early Detection of Alzheimer's Disease with Blood Plasma Proteins Using Support Vector Machines

  2020cites this paper
• Integrated lipidomics and proteomics network analysis highlights lipid and immunity pathways associated with Alzheimer’s disease

  2020cites this paper
• Cortisol associated with hypometabolism across the Alzheimer’s disease spectrum

  2019cites this paper
• The Genetic Variability of APOE in Different Human Populations and Its Implications for Longevity

  2019cites this paper
• Rowan Digital Works

  2019cites this paper
• Aging and Neuroinflammatory Disorders: New Biomarkers and Therapeutic Targets.

  2019cites this paper
• Circulating biomarkers for high-grade glioma.

  2019cites this paper
• Plasma cortisol is associated with cerebral hypometabolism across the Alzheimer's disease spectrum.

  2019cites this paper
• The complement cascade in Alzheimer’s disease: a systematic review and meta-analysis

  2019cites this paper
• Lessons Learned From Public Private Partnerships and Consortia: The ADNI Paradigm

  2019cites this paper
• A serum protein signature of APOE genotypes in centenarians

  2019cites this paper
• Analyses of Clinical Features and Investigations on Potential Mechanisms in Patients with Alzheimer’s Disease and Olfactory Dysfunction

  2018cites this paper
• Identification of Optimum Panel of Blood-based Biomarkers for Alzheimer’s Disease Diagnosis Using Machine Learning

  2018cites this paper
• Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain.

  2018cites this paper
• Uncovering Biologically Coherent Peripheral Signatures of Health and Risk for Alzheimer’s Disease in the Aging Brain

  2018cites this paper
• Decreased plasma C‐reactive protein levels in APOE ε4 allele carriers

  2018cites this paper
• Alzheimer’s Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies—Gains from AIBL and DIAN Cohort Studies

  2018cites this paper
• Cerebrospinal fluid biomarkers in Alzheimer’s Disease: from bedside to bench and back

  2017cites this paper
• Evolving Relevance of Neuroproteomics in Alzheimer's Disease.

  2017cites this paper
• Peripheral Fluid-Based Biomarkers of Alzheimer’s Disease

  2017cites this paper
• A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort

  2017cites this paper
• Using redescription mining to relate clinical and biological characteristics of cognitively impaired and Alzheimer’s disease patients

  2017cites this paper
• VEGFR2 alteration in Alzheimer’s disease

  2017cites this paper